Ascentage Pharma Group International
AAPG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.44B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.44 Billion |
|---|---|
| Enterprise Value | $1.70 Billion |
| Earnings per Share | $-13.56 |
| Beta | 0.66 |
| Outstanding Shares | 93,312,054 |
Return
| Return on Equity | -468.36% |
|---|---|
| Return on Assets | -80.41% |
| Return on Invested Capital | -184.55% |
Valuation & Multiples
| P/E Ratio | -6.63 |
|---|---|
| PEG | -18.05 |
| Price to Sales | 1.5 |
| Price to Book Ratio | 2.5 |
| Enterprise Value to Revenue | 1.66 |
| Enterprise Value to EBIT | -0.68 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.27 |
| Debt to Equity | 3.89 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.22
Consensus analyst estimateRevenue Estimate
$53.63 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
$-0.30
Consensus analyst estimateRevenue Estimate
$49.77 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 0.02% |
|---|---|
| Total Invested | $263,505▼ 63.49% |
| Investors Holding | 7▲ 1.00% |
About Ascentage Pharma Group International
767 employees
CEO: Dajun Yang
Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical cond...